Cerecor Inc. (NASDAQ: CERC) today announced that Uli Hacksell, Chairman of Cerecor and former CEO of ACADIA, has been named to the additional positions of CEO and President of the company as of January 1, 2016. Dr.

Uli Hacksell. CEO. Dr. Hacksell has served as Chairman of the Board of Directors of Adhera Therapeutics since July 2018. Dr. Hacksell has served as Chairman

Hacksell has been CEO and chairman of the board of Cerecor.Hacksell was the CEO of ACADIA Pharmaceuticals from September 2000 to March 2015, and led the company from being a private start-up to … Press Release, dated August 14, 2017, entitled “Cerecor Announces Divestiture of CERC-501 to Janssen Pharmaceuticals, Inc.” 99.3 Press Release, dated August 14, 2017, entitled “Cerecor Inc. Announces Retirement of Dr. Uli Hacksell as President and Chief Executive Officer.” Press Release, dated December 21, 2015, entitled “Cerecor Inc. Names Uli Hacksell, Chairman of Cerecor and Former CEO of ACADIA, as President and CEO.” 2 SIGNATURES Cerecor Inc. (NASDAQ: CERC) today announced that Uli Hacksell, Chairman of Cerecor and former CEO of ACADIA, has been named to the additional positions of CEO and President of the company as of January 1, 2016. Dr. Blake Paterson will step down a. 2015-12-17: EX-99.1: Publication Reports Human Brain Penetration and Target Engagement of Cerecor?s Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. CERECOR INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. CERECOR INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Uli hacksell cerecor

Bakgrund: Över 25 år i ledande befattningar på stora läkemedels- och bioteknikföretag och över 10 års erfarenhet som vd för publika bolag. Uli Hacksell Net Worth The estimated Net Worth of Uli Hacksell is at least $65.8 Mille dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $65,800 and over the last 17 years Uli sold CERC stock worth over $0. Uli Hacksell, Ph.D. Dr. Hacksell, age 68, has served on our Board since May 2015 and he was our President and Chief Executive Officer from January 2016 to August 2017.

2016-09-30 · Due to the time-sensitive nature of the SEC filings and reporting procedures, Cerecor respectfully requests that Lilly provide the acknowledgement below, to amend the effective date of the License Agreement. Sincerely, /s/ Uli Hacksell . Uli Hacksell, PhD. CEO & President. Cerecor Inc. 400 East Pratt Street, Suite 606. Baltimore, MD 21202

John Kaiser, Chief Business Officer of Cerecor, has been appointed Interim Chief Executive Officer. Cerecor Inc. Announces Retirement of Dr. Uli Hacksell as President and Chief Executive Officer. BALITIMORE, MD--(Marketwired - August 14, 2017) - Cerecor Inc. (NASDAQ: CERC), a clinical-stage biopharmaceutical company developing innovative drug candidates for patients with neurologic and neuropsychiatric disorders, today announced that Dr. Uli Hacksell has retired as Cerecor's President and BALTIMORE, MD – One day after the abrupt resignation of Chief Executive Officer Uli Hacksell, Cerecor Inc. announced it was divesting a drug therapy for major depressive order to Janssen Pharmaceuticals for up to $45 million. Cerecor said it is selling the rights to its oral kappa opioid receptor antagonist CERC-501.

* Cerecor Inc announces retirement of Dr. Uli Hacksell as president and chief executive officer * Cerecor Inc says John Kaiser, chief business officer of Cerecor, has been appointed interim chief

Cerecor Inc. 05/2015 * Cerecor Inc announces retirement of Dr. Uli Hacksell as president and chief executive officer * Cerecor Inc says John Kaiser, chief business officer of Cerecor, has been appointed interim chief Cerecor Inc. Announces Retirement of Dr. Uli Hacksell as President and Chief Executive Officer.

Education: PhD at Uppsala University. Background: Senior positions in major pharmaceutical and biotech companies for over 25 years and more than 10 years’ experience as the CEO of publicly owned companies. Exhibit 10.11 .
Stockholm central station map

Cerecor Inc. , a clinical-stage biopharmaceutical company developing innovative drug candidates for patients with neurologic and neuropsychiatric disorders, today announced that Dr. Uli Hacksell Cerecor Inc. Announces Retirement of Dr. Uli Hacksell as President and Chief Executive Officer today announced that Dr. Uli Hacksell has retired as Cerecor's President and Chief Executive neurologic and neuropsychiatric disorders, today announced that Dr. Uli Hacksell has retired as Cerecor's President and Chief Executive Officer, effective Monday, August 14, 2017.

7 apr 2021 Att stämman beslutar om val av Uli Hacksell till styrelsens ordförande. g. Att stämman Därefter har han varit vd för Cerecor och Medivir. Uli Hacksell.
Kundvard

titova vila zlatibor
johan lindeberg torekov
hastensgrillen meny
hastensgrillen meny
anna chlumsky husband

Uli Hacksell. Styrelseledamot. Styrelseledamot sedan 2019. Tidigare befattningar: VD för ACADIA Pharmaceuticals; VD och styrelseordförande i Cerecor

Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over 61,000$ and over the last 17 years Uli sold CERC stock worth over 0$. 2021-04-07 · Uli Hacksell Hacksell, född 1950, har under 30 år arbetat inom farmaceutisk industri och bioteknikbolag. Som vd för San Diego-baserade ACADIA Pharmaceuticals (2000-2015) ledde han utvecklingen från privat start-up företag till publikt mångmiljardbolag och framtagandet av det första och enda godkända läkemedlet mot psykos hos Parkinsonpatienter. 2016-09-30 · Due to the time-sensitive nature of the SEC filings and reporting procedures, Cerecor respectfully requests that Lilly provide the acknowledgement below, to amend the effective date of the License Agreement. Sincerely, /s/ Uli Hacksell .